REBEKAH MARSHALL: Open Payments
NPI 1114946043 · MILFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146 in 5 payments from 3 companies in 2025. Trend: 2023 $76 · 2024 $119 · 2025 $146
Food & beverage: $146
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $59 |
| GENZYME CORPORATION | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
Products named: DUPIXENT, FASENRA.
Industry payments across MA — which companies pay providers there.
